Greeneye has defied the market slump to raise $20 million to scale its US operation.
The Israeli company says securing this round of capital in today’s challenging economic climate is further validation of Greeneye’s mission to drive mainstream adoption of precision spraying technology in the US.
Image: Getty/TheCreativeDrone
What We’ve Learned: Unibaio on how natural microparticles can reduce chemicals in ag
‘The next two years will be incredible’. Latam investors find reasons to be cheerful
SparkLabs Cultiv8 on how to create strong financial returns and meaningful impact
Agri Trend Tracker: From BioConsortia’s latest US$15mn to Bayer’s data analysis to verify carbon reductions
